Literature DB >> 32086163

Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis.

Jessica Rice1, Cinda Hugos2, Andrea Hildebrand2, Michelle Cameron2.   

Abstract

BACKGROUND: Growing evidence supports that cannabinoids relieve MS-related spasticity but little is known about cannabis use among people with MS (PwMS) and spasticity.
OBJECTIVE: To characterize cannabis use among PwMS and spasticity.
METHODS: As part of baseline data collection for a spasticity intervention trial in Oregon, PwMS and self-reported spasticity answered questions about cannabis use.
RESULTS: 54% reported ever using cannabis and 36% currently use. 79% use multiple routes of administration, 58% use at least daily. 79% find cannabis helpful for spasticity and 26% use cannabis and prescribed oral antispasticity medications.
CONCLUSIONS: Many PwMS and spasticity use cannabis and report it helps their spasticity. Published by Elsevier B.V.

Entities:  

Keywords:  Cannabinoids; Cannabis; Multiple sclerosis; Spasticity

Mesh:

Substances:

Year:  2020        PMID: 32086163     DOI: 10.1016/j.msard.2020.102009

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

1.  Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.

Authors:  Joanie Thelen; Valeriy Zvonarev; Sarah Lam; Crystal Burkhardt; Sharon Lynch; Jared Bruce
Journal:  Mo Med       Date:  2021 May-Jun

2.  Cannabinoid use among Americans with MS: Current trends and gaps in knowledge.

Authors:  Tiffany J Braley; Daniel Whibley; Kevin N Alschuler; Dawn M Ehde; Ronald D Chervin; Daniel J Clauw; David Williams; Anna L Kratz
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-09-22

3.  A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis.

Authors:  Amber Salter; Robert J Fox; Gary Cutter; Ruth Ann Marrie; Kate E Nichol; Joshua R Steinerman; Karry M J Smith
Journal:  Int J MS Care       Date:  2021-12-29

4.  Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis.

Authors:  Ines Reynoso-Moreno; Silvia Tietz; Erika Vallini; Britta Engelhardt; Jürg Gertsch; Andrea Chicca
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-26

5.  Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis.

Authors:  Amber Salter; Gary Cutter; Ruth Ann Marrie; Kathryn Nichol; Joshua R Steinerman; Karry M J Smith; Robert J Fox
Journal:  Neurol Clin Pract       Date:  2022-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.